Vivacta Biotechnology (Shanghai) Co., Ltd.
PrivateLast Round
Series A
Apr 29, 2026
Total Funding Raised
$50M
Company Overview
Vivacta Biotechnology (Shanghai) Co., Ltd. is a biotechnology company developing in vivo CAR-T therapies for cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivacta Biotechnology (Shanghai) Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
Vivacta Biotechnology (Shanghai) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 29, 2026 |
Vivacta Biotechnology (Shanghai) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series A |
| Eisai Innovation | Series A |
| OrbiMed | Series A |
| Decheng Capital | Series A |
| Xiamen C&D Emerging Industry Equity Investment | Series A |
| Beijing Shunxi Fund | Series A |
| Hankang Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
$50M round led by Decheng Capital.
Vivacta Biotechnology (Shanghai) Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vivacta Biotechnology (Shanghai) Co., Ltd.'s valuation, stock price, and market status.
